Talyst’s Ron Strandin Becomes President of Acute Care Group, as Company Prepares to Address New Markets
Hospitals Remain the Company’s Top Focus, While It Begins Adapting Technology for Extended-Care Pharmacies
BELLEVUE, Wash.--(BUSINESS WIRE)--Talyst today named Ron Strandin president of its Acute Care Group, which will continue the company’s advancement of pharmacy technology for hospitals. He has been serving as executive vice president of sales.
“To the best of our knowledge, Talyst has the largest staff dedicated to the engineering, installation and service of central-pharmacy automation equipment in the industry”
The promotion accompanies a corporate structuring that dedicates most of the company’s current resources to the Acute Care Group, while creating a new Extended Care Group. By forming the Acute Care Group, Talyst reinforces its commitment to serving the hospital market and its unique pharmacy requirements. That group will direct most of the existing staff of more than 125, with additional staff growth expected in 2007, and will remain headquartered in Bellevue, Wash.
James E. Torina, a founder of the firm, will retain his titles of president and chief executive officer of Talyst, Inc.
The Extended Care Group will explore opportunities to apply similar technology to advance pharmacy safety and efficiency in sub-acute healthcare environments, from assisted living and skilled nursing to correctional facilities. The group will be located in Dallas.
“Ron is the perfect leader to keep Talyst customer focused concerning the needs of hospitals,” explains Torina. “By creating a separate group focused on the acute care market, we can assure our hospital customers that we remain committed to the product leadership and innovation for which Talyst has become known.”
“To the best of our knowledge, Talyst has the largest staff dedicated to the engineering, installation and service of central-pharmacy automation equipment in the industry,” notes Strandin. “Our hospital customers tell us they value that specialized focus.”
Earlier this month, Talyst received $20 million in growth funding, co-led by Ignition Partners and OVP Venture Partners. Talyst provides automation for central pharmacies, by integrating key medication handling technologies, including packaging, labeling, inventory and storage solutions, all driven by its proprietary AutoPharm® Software. The four-year-old firm has installed its systems in more than 200 hospitals across the country, and expects to double that number in the coming year. Last month, the company was ranked #33 among the state’s Fastest-Growing Private Companies, by the Puget Sound Business Journal, reflecting a doubling in year-over-year revenue.
Talyst solutions connect with all major brands of pharmacy equipment and hospital information systems, to enable quick, successful hospital implementation of medication barcoding and supply-chain tracking.
Strandin has been responsible for directing three key avenues of growth at Talyst: the direct sales force, channel partners and business development. Accomplishing sales of innovative software products for the enterprise has been a recurring theme in his career. For Rendition Networks, where he was vice president of worldwide sales, he directed a tenfold increase in revenue. Prior to that, he headed sales and marketing for Envision.
At Mosaix, he was vice president of worldwide sales, after serving as vice president of customer management applications. Both roles were focused on direct sales, dealer channels, VAR relationships and solution partners. At Lanier Worldwide, Strandin managed regional sales to the medical and legal markets, both in the United States and Canada. He holds a B.A. in business administration from Western Washington University.
Talyst enables the intelligent pharmacy. The company provides automated systems to hospitals and other centralized pharmacies, to reduce costs and increase productivity, while improving accuracy and patient safety. Talyst’s proprietary AutoPharm® software platform integrates barcoding, storage, inventory, ordering and clinical systems. For more information, see www.talyst.com or call 877-4-Talyst (877-482-5978).
AutoPharm is a registered trademark, while Talyst and Engineering the Intelligent Pharmacy are trademarks of Talyst. Other trade names are the property of their respective owners.